Skip to main content

9 October 2025

Last updated: Thursday 9 October 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The EMEA removes a spanner in the regulatory works

Monday 10 September 2007

Neuropharm finances lead candidate for treatment of autism

Monday 10 September 2007

Interviewee/Contributor

Robert Mansfield

Organisation

Neuropharm

Pagination

First page
Previous page
…
Page 83
Page 84
Page 85
Page 86
Page 87
Page 88
Page 89
Page 90
Current page 91

Organisations

DeepVerge Plc
Independent regulatory affairs professional
ReNeuron Group Plc
AstraZeneca
GW Pharmaceuticals Plc
SciTribe and BioBeat
Anavo Therapeutics BV
Inception Sciences Inc
Andera Partners
CellCentric Ltd

Interviewees and Contributers

João Ribas and Morten Graugaard Døssing
Matthias Heck
Mike Romanos and Mat Robinson
Jim Furniss
Ruth McKernan
Reinhard Kandera
Bernd Hentsch et al
Nick Seay
Ulrich Mahr
Nigel Davis

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

CHARM Therapeutics appoints CMO

Tuesday 16 September 2025

Abzena appoints CEO

Tuesday 16 September 2025

OMass Therapeutics appoints director

Tuesday 16 September 2025

Maxion Therapeutics appoints non-executive director

Tuesday 16 September 2025

AlzeCure Pharma appoints head of development

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form